Maria Berkman

Maria Berkman, MD, MBA, is the Head of the MedTech practice at Broadview Ventures where she manages the firm’s MedTech investment strategy and activity. Maria is also the Managing Director of Longview Ventures, an independent investment vehicle focused on clinical-stage opportunities as a complement to Broadview’s dedication to Seed and Series A financings.

Maria currently serves on the boards of Alleviant Medical, Aria CV, AtaCor, FineHeart, Puzzle Medical, RapidPulse, Vascular Graft Solutions, and Vectorious Medical Technologies, and previously served on the boards of Lyra Therapeutics (NSDQ:LYRA), Apama Medical (acquired), Remedy Therapeutics (acquired), and Capricor (NSDQ:CAPR).

Prior to joining Broadview Ventures, Maria was a management consultant at Monitor Group, and trained at Mass General Brigham’s Newton Wellesley Hospital. Maria earned a concurrent MD from the UCLA School of Medicine and MBA from the Anderson School of Management at UCLA, graduating Alpha Omega Alpha.
Outside of Broadview, Maria serves on the Board of Advisors at the Boston Museum of Science, and on the AdvaMed Investor Advisory Committee. Maria has also served as a VC Mentor for the UCLA Biodesign Fellowship; Co-Chair of the NEVCA MedTech Academy; SBIR/STTR reviewer for the National Science Foundation, and as an SAB Member for the RAD BioMed Accelerator in Tel Aviv, Israel.